INmune Bio advances Ebstrocel toward EMA marketing authorization
INmune Bio says it has advanced Ebstrocel toward European marketing authorization via EMA regulatory filings, per Newsdesk.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.